Clinical Trial Update: A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2a trial evaluating TAS5315 in patients with chronic spontaneous urticaria. No efficacy or safety data is presen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• TAS5315 (TAS5315)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Chronic Spontaneous Urticaria | Phase 2 | Status: COMPLETED